Clinical practice - Asymptomatic primary hyperparathyroidism

被引：195

作者：

Bilezikian, JP

Silverberg, SJ

机构：

[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA

[2] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 350卷 / 17期

关键词：

D O I：

10.1056/NEJMcp032200

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1746 / 1751

页数：6

共 46 条

[1]

Albright F., 1948, PARATHYROID GLANDS M

[2]

Alexander HR, 2002, J BONE MINER RES, V17, pN133

[3] The impact of sestamibi scanning on the outcome of parathyroid surgery [J].

Allendorf, J ;

Kim, L ;

Chabot, J ;

DiGiorgi, M ;

Spanknebel, K ;

Logerfo, P .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3015-3018

[4]

Bilezikian J. P., 1996, KIDNEY STONES MED SU, P783

[5]

Bilezikian JP, 2002, J BONE MINER RES, V17, pN2

[6] CLINICAL MANIFESTATIONS OF PRIMARY HYPERPARATHYROIDISM BEFORE AND AFTER PARATHYROIDECTOMY - A CASE-CONTROL STUDY [J].

CHAN, AK ;

DUH, QY ;

KATZ, MH ;

SIPERSTEIN, AE ;

CLARK, OH .

ANNALS OF SURGERY, 1995, 222 (03) :402-414

[7] Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism [J].

Chow, CC ;

Chan, WB ;

Li, JKY ;

Chan, NN ;

Chan, MHM ;

Ko, GTC ;

Lo, KW ;

Cockram, CS .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02) :581-587

[8] How should patients with primary hyperparathyroidism be treated? [J].

Clark, OH .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3011-3014

[9] STORY OF HYPERPARATHYROIDISM AT MASSACHUSETTS GENERAL HOSPITAL [J].

COPE, O .

NEW ENGLAND JOURNAL OF MEDICINE, 1966, 274 (21) :1174-+

[10] Longitudinal changes in bone density in hyperparathyroidism. [J].

El-Hajj Fuleihan, G ;

Moore, F ;

LeBoff, MS ;

Hurwitz, S ;

Gundberg, CM ;

Angell, J ;

Scott, J .

JOURNAL OF CLINICAL DENSITOMETRY, 1999, 2 (02) :153-162

← 1 2 3 4 5 →